⌘K

Login Start Free

Home/Filings/4/0001209191-21-042593

4//SEC Filing

Lee Tom Y 4

Accession 0001209191-21-042593

CIK 0001006028other

View on SEC.gov Company Profile

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 8:24 PM ET

Size

14.4 KB

Accession

0001209191-21-042593

Insider Transaction Report

Form 4

Period: 2021-06-16

PURE BIOSCIENCE, INC.PURE

Director

Transactions

Purchase
Common Stock
2021-06-16$0.43/sh+35,998$15,515→ 4,732,366 total
Award
Stock Option (Right to Buy)
2021-06-18+200,000→ 200,000 total
Exercise: $0.45Exp: 2031-06-18→ Common Stock (200,000 underlying)
Award
Stock Option (Right to Buy)
2021-06-18+150,000→ 150,000 total
Exercise: $0.45Exp: 2031-06-18→ Common Stock (150,000 underlying)

Holdings

Common Stock
(indirect: By Trust)
1,000,000
Common Stock
(indirect: By Spouse)
717,665
Common Stock
(indirect: By Plum Investments, L.P.)
13,401,951
Common Stock
(indirect: By Trust)
1,000,000
Common Stock
(indirect: By Trust)
1,000,000

Footnotes (5)

[F1]This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $0.425 to $0.438. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F2]Mr. Lee is the general partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P.
[F3]Mr. Lee is a trustee of the Kamika Shay Lee Trust Dated July 1, 2019, Karissa Shay Lee Trust Dated July 1, 2019 and Tessa Melody Shin Trust Dated February 12, 2020 and has voting and dispositive power with respect to these shares
[F4]The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023.
[F5]The option shares shall vest and become exercisable in four equal installments on September 18, 2021, December 18, 2021, March 18, 2022 and June 18, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

PURE BIOSCIENCE, INC.

CIK 0001006028

Entity typeother

Related Parties

1

filerCIK 0001623609

Filing Metadata

Form type: 4
Filed: Jun 21, 8:00 PM ET
Accepted: Jun 22, 8:24 PM ET
Size: 14.4 KB

View on SEC.gov